Driving Innovation: Our Progress Through Programs and Competitions

AVaTAR MedTech has continued to build exceptional global momentum through a series of awards, accelerator programs, and international recognitions that validate both the impact and potential of our technology in cardiac care.

‍

Funding & Early Validation

• In December 2023, AVaTAR secured pre-seed funding from GRIDX Exponential through a SAFE agreement, marking a foundational milestone in our early growth.

‍

Major Awards & Global Competitions

• Platinum Award Winner at the UCSF–Stanford Pediatric Device Consortium (PDC) Pitch Competition in the United States.

• Global Winner at the Cardiovascular Research Foundation (CRF) TCT® Plus Middle East Innovation Shark Tank.

• Awarded Fan Favorite Startup at the AHA EmPOWERED to Serve Business Accelerator 2024.

• Winner of the SOATT Prize  at the #SWPDC 2025 – American Academy of Pediatrics, recognizing our innovation in pediatric aortic valve reconstruction.

• Recognized as finalists in the Science Startups category of the Falling Walls Venture Global Call 2024 & 2025.

• Finalist for the Consortium for Technology & Innovation in Pediatrics (CTIP) Grant in the United States.

• Finalist and Honor Mention in NAVES 2024, the accelerator by IAE Business School.

• 2nd place – Argentina National Finals of the Entrepreneurship World Cup, hosted by the Global Entrepreneurship Network.

‍

Top-Tier Accelerator Programs & Innovation Platforms

• Selected among the top 13% of more than 1,400 applicants to pitch at the MedTech Innovator 2024 Road Tour in the United States.

• Chosen among the top 11 startups out of 300 for the AHA EmPOWERED to Serve Business Accelerator.

• Selected to join the 2025 IDEA² Program cohort at MIT linQ.

• Admitted as a portfolio company at AdvaMed, the leading U.S. medical technology association.

• Accelerated by The Blueprint Program, conducted by The Engine by MIT in Boston.

• Selected for the Biomedical Engineering Stream 2025 of Creative Destruction Lab (CDL) in Canada.

• Chosen for the Impact4Kids Program by Stanford Impact1 and i4Kids.

• Selected as an Innovator Forum startup by the Stanford Impact1 Team.

• Chosen as a Deep Tech Pioneer by Hello Tomorrow, standing out among 4,600 global applications.

• Selected for SparkLab (Batch 2024) by Universidad San Andrés in Argentina.

• Selected by the Buenos Aires Government as one of the seven startups representing the city at Project Qatar – 21st Edition in the Middle East.

‍‍

Presentations & Industry Showcases

• Participated in New York Valves 2025, The Structural Heart Summit in New York City.

• Presented at the CRF TCT Meeting in San Francisco on October 26.

‍

Our Impact, Looking Ahead

These achievements demonstrate the growing international confidence in AVaTAR MedTech’s technology, mission, and team. Through competitive awards, strategic partnerships, and global accelerator programs, we continue strengthening our path toward transforming cardiac surgery for patients worldwide.

‍